News | June 06, 2022
Merck’s pembrolizumab demonstrates improvement in distant metastasis
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
A research group led by Ben-Gurion University of the Negev managed to produce an innovative microchip for creating sperm in a culture by using a microfluidic system.
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
Opdivo-based treatments are now approved for five indications in upper gastroesophageal cancers
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
Objective tracking data combined with cohort data to drive medicine of the future
Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease that can lead to substantial burden and often disability among patients
Includes thermostabilized Ebola vaccines
Subscribe To Our Newsletter & Stay Updated
